| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.0M | +62.4% |
| Cost of Revenue | $4.9M | -74.0% |
| Gross Profit | $32.1M | +734.2% |
| R&D Expense | $46.8M | -70.0% |
| SG&A Expense | $75.9M | +16.0% |
| Operating Income | -$138.7M | +49.7% |
| Pre-tax Income | -$346.5M | -92.4% |
| Income Tax | $1.9M | — |
| Net Income | -$136.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $401.6M | +233.9% |
| Short-term Investments | $40.0M | — |
| Accounts Receivable | $21.1M | +108.4% |
| Current Assets | $471.1M | +204.9% |
| Total Assets | $544.7M | +142.2% |
| Current Liabilities | $89.7M | +2.6% |
| Total Liabilities | $91.6M | -4.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$108.7M | +40.7% |
| Capital Expenditures | $44K | -97.4% |
| Investing Cash Flow | -$39.8M | -182.5% |
| Financing Cash Flow | $429.8M | +2565.1% |
| Free Cash Flow | -$108.7M | +41.2% |
| -134.1% |
| EPS (Basic) | -$1.47 | -83.7% |
| EPS (Diluted) | -$1.47 | -83.7% |
| Stockholders' Equity |
| $618.7M |
| +562.0% |